CLINICAL TRIAL

A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2023-05-15
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

University of Wisconsin Madison

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety Addiction Pharmacology Clinical Trial Cancer Patients Treatment-Resistant Depression Safety Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II StudyClinicalTrials.gov · 2021-12-22 Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2020-01-01 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01